Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Immune mechanisms in allergic eye diseases: what is new?

Immune mechanisms in allergic eye diseases: what is new? Immune mechanisms in allergic eye diseases: what is new? Ifeoma Offiah and Virginia L. Calder Department of Ocular Biology & Therapeutics (ORBIT), Purpose of review UCL Institute of Ophthalmology, London, UK The purpose of this review will be to focus on new findings that expand our Correspondence to Virginia L. Calder, PhD, understanding of the immune mechanisms occurring in the various forms of allergic eye Department of Ocular Biology & Therapeutics (ORBIT), disease and in experimental models, and some novel therapeutic approaches. UCL Institute of Ophthalmology, 11/43 Bath Street, London EC1V 9EL, UK Recent findings Tel: +44 207 608 6848; The novel data encompass three main areas: effector mechanisms in allergic eye fax: +44 207 608 6931; v.calder@ucl.ac.uk disease; cytokines and chemokines in conjunctival responses; combinations of drugs Current Opinion in Allergy and Clinical for improving treatment options for allergic eye disease. Immunology 2009, 9:477–481 Summary The term ‘allergic eye disease’ describes a spectrum of clinical conditions, ranging from the common, milder conditions of seasonal and perennial allergic conjunctivitis (SAC, PAC), to the rare and more severe diseases, vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC). These latter two diseases can involve the cornea, leading to impaired vision. Although there http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Allergy and Clinical Immunology Wolters Kluwer Health

Immune mechanisms in allergic eye diseases: what is new?

Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/immune-mechanisms-in-allergic-eye-diseases-colon-what-is-new-quest-RNyELGxLyg

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1528-4050
eISSN
1473-6322
DOI
10.1097/ACI.0b013e3283303e2e
pmid
19620858
Publisher site
See Article on Publisher Site

Abstract

Immune mechanisms in allergic eye diseases: what is new? Ifeoma Offiah and Virginia L. Calder Department of Ocular Biology & Therapeutics (ORBIT), Purpose of review UCL Institute of Ophthalmology, London, UK The purpose of this review will be to focus on new findings that expand our Correspondence to Virginia L. Calder, PhD, understanding of the immune mechanisms occurring in the various forms of allergic eye Department of Ocular Biology & Therapeutics (ORBIT), disease and in experimental models, and some novel therapeutic approaches. UCL Institute of Ophthalmology, 11/43 Bath Street, London EC1V 9EL, UK Recent findings Tel: +44 207 608 6848; The novel data encompass three main areas: effector mechanisms in allergic eye fax: +44 207 608 6931; v.calder@ucl.ac.uk disease; cytokines and chemokines in conjunctival responses; combinations of drugs Current Opinion in Allergy and Clinical for improving treatment options for allergic eye disease. Immunology 2009, 9:477–481 Summary The term ‘allergic eye disease’ describes a spectrum of clinical conditions, ranging from the common, milder conditions of seasonal and perennial allergic conjunctivitis (SAC, PAC), to the rare and more severe diseases, vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC). These latter two diseases can involve the cornea, leading to impaired vision. Although there

Journal

Current Opinion in Allergy and Clinical Immunology – Wolters Kluwer Health

Published: Oct 1, 2009

There are no references for this article.